Skip to main content

Table 2 Treatment administered during admission and methods recognized by the patients themselves for dyspnea relief prior to hospitalization

From: Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases

 

Total N=258

Heart Failure

N=190

Respiratory Disease

N=68

p

Location and treatment administered during admission

 Intensive care unit admission

71 (27.5)

62 (32.6)

9 (13.2)

0.002

 Non-invasive mechanical ventilation

48 (18.6)

31 (16.3)

17 (25.0)

0.11

 Diuretics

216 (83.7)

187 (98.4)

29 (42.6)

0.0001

 Bronchodilators

85 (33.0)

32 (16.8)

53 (77.9)

0.0001

 Benzodiazepines

138 (53.4)

112 (58.9)

26 (38.2)

0.004

 Opioids

41 (15.9)

34 (17.9)

7 (10.3)

0.17

 MEDD (mg)

8.7±0.8

8.0±0.6

12.4±3.3

0.03

 Antidepressants

34 (13.2)

24 (12.6)

10 (14.9)

0.67

Methods used for dyspnoea relief prior to hospitalization

 Sleeping with high headboard

140 (54.3)

115 (60.5)

25 (36.8)

0.001

 Fan

16 (6.2)

15 (7.9)

1 (1.5)

0.03

 Oxygen

46 (17.8)

15 (7.9)

31 (45.6)

0.0001

 Continuous Positive Airway Pressure

24 (9.3)

11 (5.8)

13 (19.1)

0.003

 Inhalers

91 (35.3)

37 (19.5)

54 (79.4)

0.0001

 None

58 (22.5)

51 (26.8)

7 (10.3)

0.003

 Communication with GP regarding dyspnoea

153 (59.3)

98 (51.6)

54 (79.4)

0.0001

 Seeking for medical attention during admission due to acute dyspnoea

96 (37.2)

73 (38.4)

23 (33.8)

0.53

 Thinks that treatment received could be better

91 (35.3)

65 (34.2)

26 (38.2)

0.57

  1. GP General practitioner, MEDD, Morphine Equivalent Daily Dosage
  2. Data are shown as number of patients and (mean±standard deviation for Mean Morphine Equivalent Daily Dosage [MEDD]). Categorical variables are contrasted using the χ2 test and Fisher’s exact test and comparison for MEDD is made using the t test